tiprankstipranks
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market
INTS
Intensity Therapeutics, Inc.
RESEARCH TOOLSreports

Intensity Therapeutics, Inc. (INTS) Income Statement

253 Followers

Intensity Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), Intensity Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Intensity Therapeutics, Inc.'s net income was $-3.05M. See Intensity Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -26.00K$ 0.00$ -147.00K$ 0.00$ 0.00
Operating Expenses
$ 11.97M$ 16.59M$ 8.17M$ 7.55M$ 8.01M
Depreciation and Amortization
$ 0.00$ 0.00$ 147.00K$ 0.00$ 0.00
EBITDA
$ -11.97M$ -16.27M$ -10.09M$ -7.50M$ -7.88M
Operating Income
$ -11.97M$ -16.59M$ -8.32M$ -7.55M$ -8.01M
Other Income/Expenses
$ 366.00K$ 317.00K$ -2.22M$ -32.00K$ 118.58K
Pretax Income
$ -11.61M$ -16.27M$ -10.54M$ -7.58M$ -7.90M
Net Income
$ -11.61M$ -16.27M$ -10.54M$ -7.58M$ -7.90M
Per Share Metrics
Basic EPS
$ -8.56$ -29.25$ -34.50$ -55.50$ -58.00
Diluted EPS
$ -8.56$ -29.25$ -34.50$ -55.50$ -58.00
Weighted Average Shares Outstanding
 13.56M 556.24K 306.16K 136.40K 136.40K
Weighted Average Shares Outstanding (Diluted)
 13.56M----
Currency in USD

Intensity Therapeutics, Inc. Earnings and Revenue History